CompletedNot Applicable

Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt

Egypt59 participantsStarted 2020-07-07

Plain-language summary

The aim of this study is to identify demographic \& disease characteristics in pediatric oncology patients diagnosed with Ewing Sarcoma Family of Tumors (ESFT) \& treatment outcomes in these patients.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients whose age less than 19 years. Patients diagnosed with Ewing Sarcoma Family of Tumors (ESFT). Exclusion Criteria: * Patients whose age more than 19 years. Patients diagnosed with other bone \& soft tissue neoplasms.

What they're measuring

Overall survival (OS)

Timeframe: From date of treatment initiation until the date of death from any cause or patients censored at last follow up, whichever came first, assessed up to 60 months

Event Free Survival (EFS)

Timeframe: From date of treatment initiation until the date of event from any cause or patients censored at last follow up, whichever came first, assessed up to 60 months

Trial details

NCT IDNCT04300179

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-16

View on ClinicalTrials.gov More Soft Tissue Neoplasms trials